Research and innovation are the cornerstones of our business. We advance leading-edge science through a dynamic and collaborative approach. This enables us to find better solutions for treating the world’s most challenging diseases. Our clinical development teams, across the globe are focused on conducting the scientific investigation needed to help translate basic research into new therapies that will benefit patients. Our robust, innovative pipeline of products in clinical development is focused on three key therapeutic areas, oncology, dermatology and respiratory.
Glenmark Life Sciences is an Active Pharmaceutical Ingredient research and development company that partners with the world’s leading generic companies. It is owned by Glenmark Pharmaceuticals Ltd. Click here to visit Glenmark Life Sciences
Ichnos Sciences is a clinical-stage biotechnology company with a focus on innovation in oncology and autoimmune diseases owned by Glenmark Pharmaceutical Ltd. To learn more about Ichnos click here.